HEPARIN-THERAPY FOR THROMBOEMBOLIC DISORDERS - A PROSPECTIVE EVALUATION OF 134 CASES MONITORED BY THE ACTIVATED COAGULATION TIME

被引：19

作者：

HATTERSLEY, PG

MITSUOKA, JC

KING, JH

机构：

[1] UNIV CALIF DAVIS,SACRAMENTO MED CTR,SCH MED,DEPT PHARM,SACRAMENTO,CA 95817

[2] UNIV CALIF DAVIS,SACRAMENTO MED CTR,SCH MED,DEPT PATHOL,SACRAMENTO,CA 95817

[3] UNIV CALIF DAVIS,SACRAMENTO MED CTR,SCH MED,DEPT INTERNAL MED HEMATOL & ONCOL,SACRAMENTO,CA 95817

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1983年 / 250卷 / 11期

关键词：

D O I：

10.1001/jama.250.11.1413

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1413 / 1416

页数：4

共 15 条

[1] PROSPECTIVE STUDY OF VALUE OF MONITORING HEPARIN TREATMENT WITH ACTIVATED PARTIAL THROMBOPLASTIN TIME [J].

BASU, D ;

CADE, J ;

GALLUS, A ;

HIRSH, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1972, 287 (07) :324-+

[2]

BICK RL, 1980, BASIC CONCEPTS HEMOS

[3]

BULL BS, 1975, J THORAC CARDIOV SUR, V69, P685

[4] MONITORING HEPARIN THERAPY IN HEMODIALYSIS - REPORT ON ACTIVATED WHOLE-BLOOD COAGULATION TIME TESTS [J].

CONGDON, JE ;

KARDINAL, CG ;

WALLIN, JD .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1973, 226 (13) :1529-1533

[5] RANDOMIZED PROSPECTIVE TRIAL OF CONTINUOUS VS INTERMITTENT HEPARIN THERAPY [J].

GLAZIER, RL ;

CROWELL, EB .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1976, 236 (12) :1365-1367

[6] SOURCES OF ERROR IN HEPARIN-THERAPY OF THROMBOEMBOLIC DISEASE [J].

HATTERSLEY, PG ;

MITSUOKA, JC ;

KING, JH .

ARCHIVES OF INTERNAL MEDICINE, 1980, 140 (09) :1173-1175

[7] ACTIVATED COAGULATION TIME OF WHOLE BLOOD [J].

HATTERSLEY, PG .

JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1966, 196 (05) :436-+

[8]

HATTERSLEY PG, 1981, THROMB HAEMOSTASIS, V46, P382

[9]

HATTERSLEY PG, 1976, AM J CLIN PATHOL, V66, P899

[10]

HATTERSLEY PG, DRUG INTELL CLIN PHA

← 1 2 →